Back to News
Market Impact: 0.6

Under Armour, Inc. Q1 Earnings Summary

UAANDAQ
Corporate EarningsCompany FundamentalsAnalyst EstimatesCorporate Guidance & Outlook
Under Armour, Inc. Q1 Earnings Summary

Under Armour (UAA) reported a significant Q1 net loss of $305.43 million, or -$0.70 per share, a sharp reversal from last year's profit, alongside a revenue decline to $1.183 billion. Despite the headline loss, the company's adjusted earnings of $0.01 per share surpassed analyst expectations of -$0.08. UAA also provided full-year EPS guidance in the range of $0.18 to $0.20.

Analysis

Under Armour's first-quarter results present a mixed financial picture, dominated by a significant GAAP net loss and declining revenue, yet featuring a positive surprise on adjusted earnings. The company reported a substantial net loss of $305.43 million, or -$0.70 per share, which marks a stark reversal from the $10.01 million profit recorded in the same period last year. This was accompanied by a top-line contraction, with revenue falling to $1.183 billion from $1.316 billion year-over-year. However, on an adjusted basis, the company delivered earnings of $0.01 per share, decisively beating analyst consensus projections for a loss of $0.08 per share. This outperformance on adjusted EPS, despite the revenue shortfall, suggests effective cost management or the impact of significant one-time items. Looking forward, the company has issued full-year EPS guidance in the range of $0.18 to $0.20, establishing a baseline for profitability expectations for the remainder of the year.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

0.15

Ticker Sentiment

NDAQ0.00
UAA0.15

Key Decisions for Investors

  • Investors should scrutinize the drivers behind the large discrepancy between the GAAP loss of $0.70 per share and the adjusted profit of $0.01, as this is critical to understanding the underlying operational health versus the impact of one-off charges.
  • The full-year EPS guidance of $0.18-$0.20 provides a potential floor for valuation, but its credibility hinges on the company's ability to stabilize its declining revenue base, making future top-line performance the key metric to monitor.
  • Given the conflicting signals of an adjusted earnings beat against a backdrop of contracting sales and a significant reported loss, a cautious or neutral stance may be warranted until there is tangible evidence of a turnaround in revenue trends.